The pharmaceutical industry’s influence in clinical care is increasingly being viewed under a high-powered microscope, and the result is tightening restrictions on what pharma can do with/for/to doctors. Having lived through the era of sun-baked golf and beach “conferences” (with the invited physicians paid handsomely as “consultants”), this extra ...